Alzheimer Disease: all 3,765 studies
Page 29 of 38. Open to participants first (881), then studies with results posted, then the rest; newest registration first within each.
- Association Between Cerebral Arterial Vascular Flow and Sleep Apnea in Neurodegenerative AlterationsStatus unknownNCT02578303Not applicable
- Hippocampal Sclerosis and Amnesia Not Due to Alzheimer's DiseaseCompletedNCT02576821Not applicable
- Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive ImpairmentTerminatedNCT02573740Phase 1
- Yoga for Family Caregivers of Alzheimers Disease PatientCompletedNCT02563483Not applicable
- Identification of Early Markers of Alzheimer's Disease by Using Eye Tracking in Reading.CompletedNCT02557464Not applicable
- 18F-Florbetaben PET Amyloid Imaging in Case of Intermediate CSF Biology for the Diagnosis of Alzheimer's Disease : a Pilot StudyCompletedNCT02556502Not applicable
- Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mgCompletedNCT02550665Phase 3
- Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's DiseaseCompletedNCT02547818Phase 3
- Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly SubjectsCompletedNCT02546310Phase 1
- Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose)CompletedNCT02537938Phase 1
- An Evaluation of Low Level Laser Light Therapy on Improving the Symptoms of Alzheimer's DiseaseCompletedNCT02537626Not applicable
- Enhancing Working Memory in Patients With Early Alzheimer's Disease Through the Use of rTMSCompletedNCT02537496Not applicable
- Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Young Volunteers (Single-ascending Dose)CompletedNCT02534480Phase 1
- Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With TauopathiesCompletedNCT02531360Early Phase 1
- Telomerase Activator and Retinal AmyloidCompletedNCT02530255Not applicable
- Overuse of Antidepressant in Patients With Alzheimer DiseaseCompletedNCT02529436
- Cerebral Substrates of Prospective Memory in Young and Its Disruption in Normal Aging and in Alzheimer's Disease: A Study in Anatomical MRI, Diffusion Tensor MRI and Functional MRIStatus unknownNCT02522091Not applicable
- Dietary Treatments for Cognitive Impairment in Older AdultsCompletedNCT02521818Not applicable
- Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's DiseaseTerminatedNCT02521558Not applicable
- Pathological and Non-pathological Aging, Physical Activity, Genotype and CognitionCompletedNCT02520232Not applicable
- Transcranial Direct Current Stimulation (tDCS) as a Cognitive Enhancer for Patients With Alzheimers DiseaseStatus unknownNCT02518412Not applicable
- Development of Therapeutic Intervention for Sleep in Alzheimer/Caregiver DyadsWithdrawnNCT02506374
- BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)CompletedNCT02502253Phase 1
- Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer'sCompletedNCT02502045Not applicable
- Type 2 Diabetes Mellitus as Catalyst for Alzheimer's DiseaseCompletedNCT02501876
- Improving Beta-2 Adrenergic Signaling in Alzheimer's DiseaseWithdrawnNCT02500784Phase 2
- Illiteracy and Vulnerability to Alzheimer's Disease: Evaluation of Amyloid Pathology by PET ImagingCompletedNCT02494531Not applicable
- Knowing and Remembering: Cognitive and Neural Influences of Familiarity on Recognition Memory in Early Alzheimer's DiseaseCompletedNCT02492529Not applicable
- Early Identification of Markers in Alzheimer's Families / ALFAActive, not recruitingNCT02485730
- Brain Sleep Clearance of Amyloid-Beta PeptidesCompletedNCT02474251Not applicable
- Biomarker Study for Alzheimer's DiseaseCompletedNCT02472899
- Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's DiseaseCompletedNCT02471196Phase 2
- BAC in Patient With Alzheimer's Disease or Vascular DementiaWithdrawnNCT02467413Phase 2
- Macronutrient Effects on Alzheimer's Disease (MEAL-2)CompletedNCT02463084Not applicable
- Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin AspartCompletedNCT02462161Phase 1
- In Vivo Imaging of Therapeutic Electric Current FlowCompletedNCT02453763
- Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVDCompletedNCT02444637Phase 4
- Effects of Exercise on Functional Ability in People With Dementia in Nursing Homes:a Cluster Randomised Controlled TrialCompletedNCT02444078Not applicable
- Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomography Angiography in Comparison With Invasive Multimodality ImagingTerminatedNCT02440646
- Retinoic Acid Homeostasis in Neuropsychiatric DiseasesStatus unknownNCT02439099
- Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's DiseaseCompletedNCT02434718Phase 1
- Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07CompletedNCT02434666Phase 2
- Effects of Visual Arts Training on DementiaCompletedNCT02432222Not applicable
- Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) StudyCompletedNCT02420756
- Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons CentresCompletedNCT02418806Not applicable
- F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)CompletedNCT02414282
- Alzheimers Disease and Neuromarkers in Patients With Acute Hip FracturesCompletedNCT02409082
- Multi-parameter Diagnostic Blood Test for the Diagnosis of Alzheimer's DiseaseCompletedNCT02409030
- Paired Integrative Home Exercise for Seniors With Dementia and Their Caregivers (PairedPLIE)CompletedNCT02403752Not applicable
- Intervention Programs for Decreasing Caregiver Burden in Caregivers of Patients With DementiaStatus unknownNCT02397980Not applicable
- Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's DiseaseCompletedNCT02389413Phase 2
- Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's DiseaseTerminatedNCT02388152Phase 1
- Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNCT02386306Phase 1
- A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease.CompletedNCT02377713Phase 1
- Neuroinflammation and Cognitive Decline in Alzheimer DiseaseCompletedNCT02377206Early Phase 1
- Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's DiseaseCompletedNCT02370524Phase 1
- Translation of COPE for Publicly-Funded Home Care Clients and Their FamiliesCompletedNCT02365051Not applicable
- The Locus Coeruleus and MemoryStatus unknownNCT02363504
- Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease 18F-Florbetaben Positron Emission Tomography StudyTerminatedNCT02362880Not applicable
- Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD)CompletedNCT02361424Phase 2
- 24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I CompletionCompletedNCT02361242Phase 2
- Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer DementiaCompletedNCT02360657Phase 1
- Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s DiseaseCompletedNCT02360527
- Mass Practice of Activities of Daily Living in Dementia (STOMP)CompletedNCT02356055Not applicable
- Investigating the Clinical Consequences of Flutemetamol-PET-scanningTerminatedNCT02353949Phase 3
- Multi-modality MRI Study on Prediction for Mild Cognitive Impairment ConversionCompletedNCT02353884
- Construction of Diagnosis System for Early AD Based on Multi-Modality MRI TechnologyCompletedNCT02353845
- A Study of Crenezumab in Participants With Mild to Moderate Alzheimer DiseaseCompletedNCT02353598Phase 1
- Safety and Efficacy of Nabilone in Alzheimer's DiseaseCompletedNCT02351882Phase 2/3
- Patients With Alzheimer Disease, Spouse Carers and Risk of Institutionalization: a Prospective Observational Cohort Study of Dyads (AID Study)CompletedNCT02351453
- Transcranial Direct Current Stimulation for Depression in Alzheimer's Disease Patient - Preliminary ResearchTerminatedNCT02351388Not applicable
- Omental Transposition Surgery for Mild Alzheimer's DiseaseStatus unknownNCT02349191Not applicable
- Tools for Distance Delivery of an Evidence-based AD Family Caregiver InterventionCompletedNCT02347202Not applicable
- Alzheimer's Disease Imaging With PET/MRI - Beta-amyloidTerminatedNCT02343757Not applicable
- Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney FunctionCompletedNCT02340195Phase 1
- Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of DementiaCompletedNCT02333942
- Plasticity-based Adaptive Cognitive Remediation for Alzheimer DiseaseCompletedNCT02331784Not applicable
- Amyloid and Glucose PET Imaging in Alzheimer and Vascular Cognitive Impairment Patients With Significant White Matter DiseaseCompletedNCT02330510
- Safety Study of MT-4666 in Subjects With Alzheimer's DiseaseTerminatedNCT02327182Phase 3
- Reminiscence, Anxiety and Early Alzheimer's DiseaseWithdrawnNCT02319681Not applicable
- Alzheimer's Caregiver Coping: Mental and Physical HealthCompletedNCT02317523Not applicable
- Effect of Electroacupuncture Combined With Donepezil for Treating Alzheimer's DiseaseStatus unknownNCT02305836Phase 2
- Relationship Between Protein Biomarkers in Cerebrospinal Fluid and Alzheimer&Apos;s Disease in Patients With DepressionTerminatedNCT02303158
- Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education ProgramCompletedNCT02300584Not applicable
- Memory Problems Perceptions Among Patients and Accompaniers During Diagnosis Process :Status unknownNCT02299154Not applicable
- Hearing Instruments in Alzheimer's DiseaseCompletedNCT02294513
- An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's DiseaseCompletedNCT02293915Phase 3
- Phase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive ImpairmentCompletedNCT02291783Phase 1
- Gray Matters Alzheimer's Disease Prevention InterventionCompletedNCT02290912Not applicable
- Tau Imaging in Young Onset DementiaCompletedNCT02289118
- Prediction of Cognitive Properties of Memantine for Neurodegenerative DiseasesTerminatedNCT02288000Phase 1
- ATP in Alzheimer DiseaseCompletedNCT02279511Phase 2
- The Use of EEG in Alzheimer's Disease, With and Without Scopolamine - A Pilot StudyCompletedNCT02273895Not applicable
- Sound Estimation and Accuracy TaskCompletedNCT02271685Not applicable
- Exploratory Study for the Validity of QuQu ScaleCompletedNCT02267486
- Behavioral Interventions to Prevent or Delay DementiaCompletedNCT02265757Not applicable
- MEMENTO-VAScular COmponents of DementiaCompletedNCT02264899Not applicable
- LESCOD: "Lewy Body Screening in Cognitive Disorders"TerminatedNCT02263287Not applicable
- In Vivo Alzheimer ProteomicsTerminatedNCT02263235Not applicable
- A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS)CompletedNCT02262975